AIFU lacks a meaningful current analyst price-target consensus. MarketBeat lists only a single "Sell" rating from Weiss Ratings, a quantitative provider rather than traditional sell-side research, and shows no consensus price target (N/A). MarketScreener includes one older figure near $6, but it ties to pre-split data and cannot serve as a reliable current benchmark. With fewer than two credible analyst targets above the present price, the discussion here relies on a publicly circulated technical objective instead of an analyst aggregate.
In public commentary and algorithmic forecast platforms, a year-end objective near $11.80 has appeared for AIFU, with longer-term projections around $15 by 2030. Rounded, these point to $12 as a clean reference level. This remains a publicly discussed technical target, not an official published consensus, and carries less weight than a multi-analyst aggregate.
At a recent quote near $8.40, AIFU would need to advance roughly 43% to reach $12. That represents a substantial move, particularly for a company posting negative earnings and a recent history of value erosion. The path would likely hinge on two elements: stabilization of the insurance distribution business with a return to revenue growth, and credible execution on newer AI and industrial-technology initiatives. Absent those, the stock's direction has been shaped more by technical and listing-compliance factors than by fundamentals.
It is worth noting that AIFU has already traded at and above $10 at times in recent months, so the $12 objective is not far distant in absolute terms. Still, given the sharp year-to-date decline even after reverse-split adjustments, the required move would signal a genuine shift in investor sentiment rather than a modest rebound.
Reliable technical levels for AIFU prove difficult to establish because the two reverse splits have distorted historical price charts and range data. The $10 area has acted as a rough psychological zone in recent trading, and $12 would sit just above it. Given the stock's extreme volatility and thin average trading volume, conventional support and resistance levels warrant caution; price discovery stays unusually noisy for this micro-cap. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
Algorithmic and technical objectives such as the $12 figure generally imply a horizon of roughly twelve months, though they are not formal research forecasts. Investors evaluating the target should monitor upcoming earnings and revenue guidance for signs of stabilization, any progress or termination of the Peakleap Ventures MOU, the terms and completion of the $135 million private placement, and any Nasdaq listing-compliance developments. Given the stock's sensitivity, regulatory and macroeconomic headlines out of China also matter. From what I see, this is important because fundamentals remain weak and technical signals dominate.
In my own research process I frequently turn to Tickeron’s AI Daily Buy/Sell Signals to monitor volatile names like this one. The tool applies artificial intelligence to scan thousands of stocks and ETFs, producing Buy, Sell, or Hold signals based on shifting market conditions, technical behavior, and AI-driven analysis. For a micro-cap with weak fundamentals where technical factors often lead price action, these signals can help surface opportunities, track positions, and identify trend changes more efficiently than manual chart review alone. I have found it useful for staying objective amid the noise.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where AIFU declined for three days, in 320 of 345 cases, the price declined further within the following month. The odds of a continued downward trend are 90%.
The Aroon Indicator for AIFU entered a downward trend on November 12, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where AIFU's RSI Indicator exited the oversold zone, 43 of 50 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 86%.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 55 of 69 cases where AIFU's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 80%.
The Momentum Indicator moved above the 0 level on November 12, 2026. You may want to consider a long position or call options on AIFU as a result. In 67 of 98 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 68%.
The Moving Average Convergence Divergence (MACD) for AIFU just turned positive on November 12, 2026. Looking at past instances where AIFU's MACD turned positive, the stock continued to rise in 35 of 45 cases over the following month. The odds of a continued upward trend are 78%.
Following a +10.79% 3-day Advance, the price is estimated to grow further. Considering data from situations where AIFU advanced for three days, in 185 of 243 cases, the price rose further within the following month. The odds of a continued upward trend are 76%.
AIFU may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Tickeron Valuation Rating of 13 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.043) is normal, around the industry mean (2.681). P/E Ratio (-0.003) is within average values for comparable stocks, (19.012). Projected Growth (PEG Ratio) (0.040) is also within normal values, averaging (8.322). Dividend Yield (0.021) settles around the average of (0.039) among similar stocks. P/S Ratio (0.064) is also within normal values, averaging (2.968).
The Tickeron Price Growth Rating for this company is 94 (best 1 - 100 worst), indicating slightly worse than average price growth. AIFU’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 98 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 99 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. AIFU’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 86, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a provider of property and casualty insurance brokerage services
Industry InsuranceBrokersServices